Professor Stéphane Zuily is a cardiovascular specialist in the Department of Vascular Medicine at Nancy Academic Hospital. His clinical activities include the management of all common vascular diseases (e.g. thrombosis, PAD, aneurysms, acrosyndrome) as well as rare diseases of arteries, veins, lymphatics and microcirculation. His research activities are oriented towards thrombosis especially the antiphospholipid syndrome. He's the national investigator coordinator in charge of the COVI-DOSE trial (NCT04373707) identifying the best anticoagulant strategy to prevent thrombosis in COVID-19 patients. He is the vice-president of the Conseil National Professionnel of Vascular Medicine, general secretary (2017-2020) of the French Society of Vascular Medicine and is a member of several scientific societies (SFC, SFMV, ESC, ISTH).